Tacere Therapeutics
San Jose, California, United States
About Tacere Therapeutics
Tacere Therapeutics, Inc. specializes in the development of novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). Combining expertise in RNA interference (RNAi), gene medicine, and novel biologicals, Tacere possesses proprietary skill in the identification and development of RNAi therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Seed (Oct 2006)
- Website: tacerebio.com
- Phone: (408)960-2205
Industries & Categories
Biotechnology, Genetics
Social Profiles
Canonical: https://fsome.com/organization/tacere-therapeutics-2461757 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.